title: Intravenous immunoglobulins in the treatment of immune neuropathies.
abstract: OBJECTIVE
  The aim of this review is to describe the value of high-dose polyclonal intravenous immunoglobulins as a treatment option in autoimmune disorders affecting the peripheral nervous system.
  
  
  RESULTS
  A randomized placebo-controlled trial in patients with chronic inflammatory demyelinating polyradiculoneuropathy revealed short-term and long-term efficacy and safety of intravenous immunoglobulins as a treatment option for the chronically inflamed peripheral nervous system. Case reports suggest that the subcutaneous administration of immunoglobulins may represent a convenient alternative.
  
  
  CONCLUSIONS
  Intravenous immunoglobulin represents an effective and safe treatment option in patients with autoimmune-mediated diseases affecting the peripheral nerves.
authors.affiliation: Department of Neurology, Heinrich-Heine-University, Duesseldorf, Germany. bernd.kieseier@uni-duesseldorf.de
authors.forename: Bernd C
authors.initials: BC
authors.lastname: Kieseier
authors.forename: Gerd
authors.initials: G
authors.lastname: Meyer Zu Hörste
authors.forename: Helmar C
authors.initials: HC
authors.lastname: Lehmann
authors.forename: Ralf
authors.initials: R
authors.lastname: Gold
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Hartung